{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:50:08Z","timestamp":1780325408746,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.vaccine.2011.10.095","type":"journal-article","created":{"date-parts":[[2011,11,8]],"date-time":"2011-11-08T23:45:12Z","timestamp":1320795912000},"page":"300-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1.3)"],"prefix":"10.1016","volume":"30","author":[{"given":"Chun Fang","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Lanthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny","family":"Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Beath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Beresford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amine","family":"Kamen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.10.095_bib0005","first-page":"309","article-title":"Position paper","volume":"85","author":"WHO","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"issue":"Jul (30)","key":"10.1016\/j.vaccine.2011.10.095_bib0010","doi-asserted-by":"crossref","first-page":"589","DOI":"10.7589\/0090-3558-42.3.589","article-title":"Behavior, movements, and demographics of rabid raccoons in Ontario, Canada: management implications","volume":"42","author":"Rosatte","year":"2006","journal-title":"J Wildl Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.10.095_bib0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.7589\/0090-3558-37.1.119","article-title":"Elimination of rabies from red foxes in eastern Ontario","volume":"37","author":"MacInnes","year":"2001","journal-title":"J Wildl Dis"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2011.10.095_bib0020","doi-asserted-by":"crossref","first-page":"772","DOI":"10.7589\/0090-3558-45.3.772","article-title":"The control of raccoon rabies in Ontario Canada: proactive and reactive tactics, 1994\u20132007","volume":"45","author":"Rosatte","year":"2009","journal-title":"J Wildl Dis"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.10.095_bib0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.virusres.2005.03.012","article-title":"Status of oral rabies vaccination in wild carnivores in the United States","volume":"111","author":"Slate","year":"2005","journal-title":"Virus Res"},{"issue":"November (47)","key":"10.1016\/j.vaccine.2011.10.095_bib0030","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1016\/j.vaccine.2009.08.005","article-title":"Safety studies on an adenovirus recombinant vaccine for rabies (AdRG1.3-ONRAB) in target and non-target species","volume":"27","author":"Knowles","year":"2009","journal-title":"Vaccine"},{"issue":"May (20)","key":"10.1016\/j.vaccine.2011.10.095_bib0035","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/j.vaccine.2009.02.074","article-title":"In vitro and in vivo genetic stability studies of a human adenovirus type 5 recombinant rabies glycoprotein vaccine (ONRAB)","volume":"27","author":"Knowles","year":"2009","journal-title":"Vaccine"},{"issue":"September (13)","key":"10.1016\/j.vaccine.2011.10.095_bib0040","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0264-410X(96)00012-6","article-title":"Human adenovirus type 5 vectors expressing rabies glycoprotein","volume":"14","author":"Yarosh","year":"1996","journal-title":"Vaccine"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.10.095_bib0045","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1089\/hum.2004.15.1022","article-title":"Biology of adenovirus and its use as a vector for gene therapy","volume":"15","author":"McConnell","year":"2004","journal-title":"Hum Gene Ther"},{"issue":"May (1)","key":"10.1016\/j.vaccine.2011.10.095_bib0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12033-007-0021-5","article-title":"Adenoviral vectors for gene therapy","volume":"36","author":"Douglas","year":"2007","journal-title":"Mol Biotechnol"},{"issue":"October (Suppl. 1)","key":"10.1016\/j.vaccine.2011.10.095_bib0055","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1038\/sj.gt.3302618","article-title":"Use of adenoviral vectors as veterinary vaccines","volume":"12","author":"Ferreira","year":"2005","journal-title":"Gene Ther"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.10.095_bib0060","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1586\/erv.09.29","article-title":"Strategies to overcome host immunity to adenovirus vectors in vaccine development","volume":"8","author":"Thacker","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"November\u2013December (6)","key":"10.1016\/j.vaccine.2011.10.095_bib0065","first-page":"2","article-title":"Jesse Gelsinger","volume":"34","author":"Gelsinger","year":"2000","journal-title":"FDA Consum"},{"issue":"November (9653)","key":"10.1016\/j.vaccine.2011.10.095_bib0070","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept step study: a case-cohort analysis","volume":"372","author":"McElrath","year":"2008","journal-title":"Lancet"},{"issue":"November (9653)","key":"10.1016\/j.vaccine.2011.10.095_bib0075","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the step study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"issue":"July (1\u20133)","key":"10.1016\/j.vaccine.2011.10.095_bib0080","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1008040221630","article-title":"Comparison of manufacturing techniques for adenovirus production","volume":"30","author":"Iyer","year":"1999","journal-title":"Cytotechnology"},{"issue":"February (Suppl. 1)","key":"10.1016\/j.vaccine.2011.10.095_bib0085","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1002\/jgm.503","article-title":"Development and optimization of an adenovirus production process","volume":"6","author":"Kamen","year":"2004","journal-title":"J Gene Med"},{"issue":"March\u2013April (2)","key":"10.1016\/j.vaccine.2011.10.095_bib0090","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.biotechadv.2008.10.003","article-title":"From the first to the third generation adenoviral vector: what parameters are governing the production yield?","volume":"27","author":"Dormond","year":"2009","journal-title":"Biotechnol Adv"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.10.095_bib0095","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/btpr.286","article-title":"Reassessing culture media and critical metabolites that affect adenovirus production","volume":"26","author":"Shen","year":"2010","journal-title":"Biotechnol Prog"},{"issue":"March (Pt 3)","key":"10.1016\/j.vaccine.2011.10.095_bib0100","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1099\/0022-1317-68-3-937","article-title":"Growth of 293 cells in suspension culture","volume":"68","author":"Graham","year":"1987","journal-title":"J Gen Virol"},{"issue":"April (3)","key":"10.1016\/j.vaccine.2011.10.095_bib0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10616-009-9208-x","article-title":"Adenovirus vector production using low-multiplicity infection of 293 cells","volume":"59","author":"Yamada","year":"2009","journal-title":"Cytotechnology"},{"issue":"May (1\u20132)","key":"10.1016\/j.vaccine.2011.10.095_bib0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0378-4347(00)00597-1","article-title":"Improved high-performance liquid chromatographic method in the analysis of adenovirus particles","volume":"755","author":"Klyushnichenko","year":"2001","journal-title":"J Chromatogr B: Biomed Sci Appl"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.10.095_bib0115","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7589\/0090-3558-45.2.363","article-title":"Aerial distribution of ONRAB baits as a tactic to control rabies in raccoons and striped skunks in Ontario, Canada","volume":"45","author":"Rosatte","year":"2009","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2011.10.095_bib0120","unstructured":"Xie L, Goochee, CF. Inventors. Methods of adenovirus production. US patent 7344873; February 17, 2008."},{"issue":"September (6)","key":"10.1016\/j.vaccine.2011.10.095_bib0125","first-page":"613","article-title":"Improvement of recombinant protein production with the human adenovirus\/293S expression system using fed-batch strategies","volume":"51","author":"Nadeau","year":"1996","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2011.10.095_bib0130","unstructured":"Luitjens A, Lewis JA. Inventors. Method for the production of adenoviral vectors. WO 2010\/060719; June 3, 2010"},{"issue":"May\u2013June (3)","key":"10.1016\/j.vaccine.2011.10.095_bib0135","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1021\/bp034237l","article-title":"High-titer adenovirus vector production in 293S cell perfusion culture","volume":"20","author":"Cortin","year":"2004","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.vaccine.2011.10.095_bib0140","series-title":"Competitive ELISA for the detection of rabies virus neutralizing antibodies","author":"Elmgren","year":"1996"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.10.095_bib0145","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1128\/JVI.73.8.6903-6915.1999","article-title":"A recombinant measles vaccine virus expressing wild-type glycoproteins: consequences for viral spread and cell tropism","volume":"73","author":"Johnston","year":"1999","journal-title":"J Virol"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.10.095_bib0150","doi-asserted-by":"crossref","first-page":"459","DOI":"10.7589\/0090-3558-47.2.459","article-title":"High-density baiting with ONRAB(R) rabies vaccine baits to control Arctic-variant rabies in striped skunks in Ontario Canada","volume":"47","author":"Rosatte","year":"2011","journal-title":"J Wildl Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11017452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11017452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:18:46Z","timestamp":1759400326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11017452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0264410X11017452"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.10.095","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1.3)","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.10.095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2011 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}